YIL781

• CAT Number: R042382
• CAS Number: 875258-85-8
• Molecular Formula: C24H28FN3O2
• Molecular Weight: 409.50
• Purity: ≥95%
• Synonyms: 6-(4-fluorophenoxy)-2-methyl-3-[[(3S)-1-propan-2-ylpiperidin-3-yl]methyl]quinazolin-4-one
• InChI: InChI=1S/C24H28FN3O2/c1-16(2)27-12-4-5-18(14-27)15-28-17(3)26-23-11-10-21(13-22(23)24(28)29)30-20-8-6-19(25)7-9-20/h6-11,13,16,18H,4-5,12,14-15H2,1-3H3/t18-/m0/s1
• InChIKey: FRKXOBMDEXCHHD-SFHVURJKSA-N
• SMILES: CC1=NC2=C(C=C(C=C2)OC3=CC=C(C=C3)F)C(=O)N1C[C@H]4CCCN(C4)C(C)C

YIL781（Cat No.:R042382）is a novel small molecule inhibitor being developed for the treatment of cancers, particularly those that exhibit resistance to conventional therapies. It targets specific signaling pathways involved in tumor cell proliferation, survival, and metastasis, with a focus on disrupting the function of key proteins that drive cancer progression. Preclinical studies have shown promising results, indicating that YIL781 could enhance the effectiveness of existing cancer treatments and overcome resistance mechanisms. Ongoing clinical trials are evaluating its safety, efficacy, and potential as a targeted therapy for various solid tumors and hematologic cancers.